ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway
Ontology highlight
ABSTRACT: This SuperSeries is composed of the SubSeries listed below.
ORGANISM(S): Homo sapiens
PROVIDER: GSE132617 | GEO | 2020/06/12
REPOSITORIES: GEO
ACCESS DATA